Tesamorelin
FDA-Approved Growth Hormone Releasing Peptide
The only FDA-approved GHRH analog for reducing visceral adipose tissue, with proven benefits for body composition and metabolic health.
Prescription Required
Can't get Tesamorelin through your GP? These telemedicine providers specialize in peptide therapy.
Everlywell
FDA-approved tesamorelin and comprehensive peptide therapy with at-home testing.
Hone Health
Hormone optimization & peptide therapy for men. At-home testing with physician oversight.
Marek Health
Comprehensive hormone and peptide protocols with detailed blood work analysis.
Everlife.md
Peptide-focused telemedicine platform with personalized protocols and ongoing monitoring.
Peter MD
Telemedicine platform specializing in peptide therapy and hormone optimization.
Defy Medical
Established telemedicine clinic offering peptides, HRT, and regenerative therapies.
Always consult with a licensed physician before starting any peptide therapy.
About Tesamorelin
Tesamorelin (brand name Egrifta) is a synthetic growth hormone-releasing hormone (GHRH) analog that has gained FDA approval for the treatment of HIV-associated lipodystrophy. Unlike many other peptides, Tesamorelin has undergone rigorous clinical trials and is prescribed by physicians for its proven ability to reduce visceral adipose tissue (VAT)—the dangerous fat that surrounds internal organs. Research has shown it can reduce trunk fat by up to 18% while preserving subcutaneous fat and lean muscle mass. Tesamorelin works by stimulating the pituitary gland to produce and release natural growth hormone, making it a preferred option for those seeking the benefits of optimized GH levels through a medically-supervised approach.
Mechanism of Action
Tesamorelin is a 44-amino acid synthetic peptide analog of human growth hormone-releasing hormone (GHRH). It binds to GHRH receptors on somatotroph cells in the anterior pituitary gland, stimulating the synthesis and pulsatile release of endogenous growth hormone. This mechanism preserves the body's natural feedback regulation, resulting in physiological GH pulses rather than constant elevation. The increased GH then promotes lipolysis (fat breakdown), particularly in visceral adipose tissue, while supporting lean tissue maintenance.
How Tesamorelin Works in Your Body:
- Target Receptors: Tesamorelin binds to specific receptors that trigger downstream signaling cascades related to its primary benefits.
- Physiological Response: The body responds by modulating natural processes—whether hormone release, tissue repair, or cellular signaling—without replacing endogenous function.
- Timeline: Effects typically begin within a few days, with optimal results seen over the recommended protocol duration.
Dosing Protocol
Frequency
Once daily
Timing
Before bed or in the morning on empty stomach
Duration
Ongoing with physician supervision
Important Notes
Subcutaneous injection. Prescription required. Regular monitoring of IGF-1 levels recommended.
Clinical Research
3 studies on Tesamorelin
Visceral Adipose Tissue Reduction
Tesamorelin reduced trunk fat by 15-18% in HIV patients with lipodystrophy over 26 weeks, with maintained effects during continued treatment.
New England Journal of Medicine
Cardiovascular Risk Markers
Treatment improved triglyceride levels and other cardiovascular risk markers in patients with excess visceral fat.
Journal of Clinical Endocrinology & Metabolism
Cognitive Function in Aging
Preliminary studies suggest potential cognitive benefits in older adults, with improvements in executive function and verbal memory.
Archives of Neurology
Growth Hormone Peptides Compared
Compare mechanism of action, FDA status, and use cases for the most popular growth hormone releasing peptides.
| Peptide | FDA Status | Mechanism | GH Release | Side Effects | Best For | Details |
|---|---|---|---|---|---|---|
Tesamorelin FDA-Approved GHRH Analog | FDA Approved | Binds GHRH receptors on pituitary, stimulating natural GH synthesis and pulsatile release | strong | moderate | Those seeking FDA-approved option for visceral fat reduction with physician oversight | View |
Sermorelin The Gold Standard GHRH | Compounded | First 29 amino acids of GHRH, triggers natural pulsatile GH release during sleep | moderate | minimal | Beginners seeking gentle GH optimization with excellent safety profile | View |
CJC-1295 Extended-Release GHRH | Research | Modified GHRH with DAC for extended half-life, sustained GH elevation over days | strong | moderate | Those wanting less frequent dosing with sustained GH benefits | View |
Ipamorelin Clean GH Secretagogue | Research | Selective ghrelin receptor agonist, triggers GH pulse without affecting cortisol/prolactin | moderate | minimal | Those wanting clean GH elevation without hormonal disruption | View |
Tesamorelin
FDA-Approved GHRH Analog
GH Release
Side Effects
Primary Uses
Those seeking FDA-approved option for visceral fat reduction with physician oversight
Learn MoreSermorelin
The Gold Standard GHRH
GH Release
Side Effects
Primary Uses
Beginners seeking gentle GH optimization with excellent safety profile
Learn MoreCJC-1295
Extended-Release GHRH
GH Release
Side Effects
Primary Uses
Those wanting less frequent dosing with sustained GH benefits
Learn MoreIpamorelin
Clean GH Secretagogue
GH Release
Side Effects
Primary Uses
Those wanting clean GH elevation without hormonal disruption
Learn MoreFDA-Approved Option
Tesamorelin is the only FDA-approved GHRH analog, offering the highest level of regulatory oversight for visceral fat reduction.
Beginner-Friendly
Sermorelin and Ipamorelin offer excellent tolerability profiles, making them ideal starting points for GH optimization.
Synergistic Stacking
GHRH peptides (Sermorelin, CJC-1295) can be stacked with GHRPs (Ipamorelin) for enhanced, synergistic GH release.
Frequently Asked Questions About Tesamorelin
Is Tesamorelin FDA approved?▾
How much visceral fat can Tesamorelin reduce?▾
What is the difference between Tesamorelin and Sermorelin?▾
Important Safety Information
Medical Disclaimer: The information provided about Tesamorelin is for educational purposes only and is not intended as medical advice. Always consult with a qualified healthcare provider before starting any new supplement or peptide protocol.
Research Status: While Tesamorelin has shown promising results in research studies, many peptides are still being studied and may not be approved by regulatory bodies like the FDA for specific uses. The research cited represents ongoing scientific investigation.
Individual Variation: Responses to peptides vary significantly between individuals. What works for one person may not work for another. Side effects, while generally mild, can occur and should be monitored closely.
Quality & Sourcing: If you choose to use peptides, ensure you obtain them from reputable, tested sources. Peptide quality, purity, and proper storage are critical for safety and efficacy.
Legal Considerations: Peptide regulations vary by country and jurisdiction. Some peptides may require a prescription or may have restrictions on their use. Research the laws in your area before obtaining or using peptides.